Variant report
Variant | nsv870844 |
---|---|
Chromosome Location | chr1:103785095-104017778 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:310)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:28)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr1:103913905-103914207 | IMR90 | lung: | n/a | n/a |
2 | CEBPB | chr1:103913892-103914282 | ECC-1 | luminal epithelium: | n/a | n/a |
3 | CEBPB | chr1:103915238-103916001 | A549 | lung: | n/a | n/a |
4 | CEBPB | chr1:103913925-103914207 | A549 | lung: | n/a | n/a |
5 | CEBPB | chr1:103916459-103916756 | IMR90 | lung: | n/a | chr1:103916605-103916616 |
6 | CEBPB | chr1:103913878-103914176 | ECC-1 | luminal epithelium: | n/a | n/a |
7 | CEBPB | chr1:104017575-104017817 | HepG2 | liver: | n/a | chr1:104017690-104017701 |
8 | CEBPB | chr1:103913942-103914216 | A549 | lung: | n/a | n/a |
9 | CEBPB | chr1:103916506-103916758 | A549 | lung: | n/a | chr1:103916605-103916616 |
10 | CEBPB | chr1:103913873-103914258 | Hela-S3 | cervix: | n/a | n/a |
11 | CEBPB | chr1:104017550-104017878 | IMR90 | lung: | n/a | chr1:104017690-104017701 |
12 | CEBPB | chr1:103916500-103916774 | HepG2 | liver: | n/a | chr1:103916605-103916616 |
13 | CTCF | chr1:103804417-103804596 | GM19239 | blood: | n/a | n/a |
14 | CTCF | chr1:103827959-103827984 | GM20000 | blood: | n/a | n/a |
15 | CTCF | chr1:104003866-104004064 | A549 | lung: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
16 | CTCF | chr1:103804445-103804570 | GM10266 | blood: | n/a | n/a |
17 | CTCF | chr1:104003840-104003990 | HCM | heart: | n/a | n/a |
18 | CTCF | chr1:104003900-104004050 | HepG2 | liver: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
19 | CTCF | chr1:103944181-103944287 | GM10266 | blood: | n/a | n/a |
20 | CTCF | chr1:104003960-104004110 | GM12875 | blood: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
21 | CTCF | chr1:103959701-103959747 | Kidney_OC | kidney: | n/a | n/a |
22 | CTCF | chr1:103994352-103994366 | GM20000 | blood: | n/a | n/a |
23 | CTCF | chr1:103797914-103797922 | GM13977 | blood: | n/a | n/a |
24 | CTCF | chr1:103804431-103804573 | GM13976 | blood: | n/a | n/a |
25 | CTCF | chr1:104003960-104004110 | SK-N-SH_RA | brain: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
26 | CTCF | chr1:103819399-103819493 | GM20000 | blood: | n/a | n/a |
27 | CTCF | chr1:104003840-104003990 | HCT-116 | colon: | n/a | n/a |
28 | CTCF | chr1:104003880-104004030 | GM12865 | blood: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
29 | CTCF | chr1:104003940-104004090 | HPF | lung: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
30 | CTCF | chr1:103820011-103820065 | Fibrobl | skin: | n/a | n/a |
31 | CTCF | chr1:104003889-104004110 | LNCaP | prostate: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
32 | CTCF | chr1:103944159-103944298 | NHEK | skin: | n/a | n/a |
33 | CTCF | chr1:104003880-104004030 | SAEC | small airway: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
34 | CTCF | chr1:104003920-104004070 | GM12870 | blood: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
35 | CTCF | chr1:104003900-104004050 | NHEK | skin: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
36 | CTCF | chr1:104003900-104004050 | Caco-2 | colon: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
37 | CTCF | chr1:103804448-103804559 | LNCaP | prostate: | n/a | n/a |
38 | CTCF | chr1:103804397-103804615 | GM12892 | blood: | n/a | n/a |
39 | CTCF | chr1:104004000-104004150 | HVMF | connective: | n/a | n/a |
40 | CTCF | chr1:103804386-103804594 | GM19240 | blood: | n/a | n/a |
41 | CTCF | chr1:104003960-104004110 | GM12864 | blood: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
42 | CTCF | chr1:104003940-104004090 | AG10803 | skin: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
43 | CTCF | chr1:104004040-104004190 | HFF-Myc | foreskin: | n/a | n/a |
44 | CTCF | chr1:104003927-104004117 | GM20000 | blood: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
45 | CTCF | chr1:104003391-104003493 | Lung_OC | lung: | n/a | n/a |
46 | CTCF | chr1:103944157-103944329 | GM13977 | blood: | n/a | n/a |
47 | CTCF | chr1:104003920-104004070 | GM12865 | blood: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
48 | CTCF | chr1:104003760-104003910 | HA-sp | spinal cord: | n/a | n/a |
49 | CTCF | chr1:104003900-104004050 | HBMEC | blood vessel: | n/a | chr1:104003995-104004013 chr1:104003990-104004011 |
50 | CTCF | chr1:104003840-104003990 | HFF | foreskin: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
(count:28 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RNPC3-2 | chr1:103827995-103828355 | XLOC_000324 |
2 | lnc-AMY1B-1 | chr1:103835781-103835986 | XLOC_000945 |
3 | lnc-AMY1B-1 | chr1:104011964-104012012 | ENSG00000224613.2 |
4 | lnc-AMY1B-1 | chr1:103820969-103821114 | XLOC_000945 |
5 | lnc-AMY1B-1 | chr1:103835781-103835986 | XLOC_000945 |
6 | lnc-AMY1B-1 | chr1:103971909-103971995 | XLOC_000945 |
7 | lnc-AMY1B-1 | chr1:103832177-103832263 | XLOC_000945 |
8 | lnc-AMY1B-1 | chr1:103821644-103821705 | XLOC_000945 |
9 | lnc-AMY1B-1 | chr1:103975513-103975718 | ENSG00000224613.2 |
10 | lnc-AMY1B-1 | chr1:103971909-103971995 | ENSG00000224613.2 |
11 | lnc-AMY1B-1 | chr1:103961376-103961437 | XLOC_000945 |
12 | lnc-AMY1B-1 | chr1:103971909-103971995 | XLOC_000945 |
13 | lnc-AMY1B-1 | chr1:103832177-103832263 | XLOC_000945 |
14 | lnc-RNPC3-1 | chr1:103967727-103968087 | XLOC_000325 |
15 | lnc-RNPC3-1 | chr1:103957501-103957557 | XLOC_000325 |
16 | lnc-AMY1B-1 | chr1:103975600-103975718 | XLOC_000945 |
17 | lnc-AMY1B-1 | chr1:103971909-103971995 | XLOC_000945 |
18 | lnc-AMY1B-1 | chr1:104011964-104012014 | XLOC_000945 |
19 | lnc-AMY1B-1 | chr1:103975513-103975718 | XLOC_000945 |
20 | lnc-AMY1B-1 | chr1:103975513-103975718 | XLOC_000945 |
21 | lnc-AMY1B-1 | chr1:103821659-103821705 | XLOC_000945 |
22 | lnc-AMY1B-1 | chr1:103961391-103961437 | XLOC_000945 |
23 | lnc-AMY1B-1 | chr1:103975513-103975718 | XLOC_000945 |
24 | lnc-AMY1B-1 | chr1:103975513-103975718 | XLOC_000945 |
25 | lnc-RNPC3-2 | chr1:103817769-103817825 | XLOC_000324 |
26 | lnc-AMY1B-1 | chr1:103961376-103961437 | ENSG00000224613.2 |
27 | lnc-AMY1B-1 | chr1:103960701-103960846 | XLOC_000945 |
28 | lnc-AMY1B-1 | chr1:103971909-103971995 | XLOC_000945 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000230759 | TF binding region |
ENSG00000234037 | TF binding region |
ENSG00000232753 | TF binding region |
DYRK2 | miRNA target sites |
TOMM20 | miRNA target sites |
EGR1 | miRNA target sites |
TOM1L2 | miRNA target sites |
TOMM34 | miRNA target sites |
EGR2 | miRNA target sites |
EGLN3 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373074218 | chr1:103913956-103913957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs370484358 | chr1:103914004-103914005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs563491636 | chr1:103914016-103914017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs531042218 | chr1:103914126-103914127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147990333 | chr1:103914211-103914212 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs141617544 | chr1:103914216-103914217 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs535635987 | chr1:103914257-103914258 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547421572 | chr1:103914277-103914278 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534503431 | chr1:103914298-103914299 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150080245 | chr1:103914355-103914356 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs115215576 | chr1:103914369-103914370 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28576594 | chr1:103914533-103914534 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575921487 | chr1:103914542-103914543 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138739047 | chr1:103914598-103914599 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376020376 | chr1:103914600-103914601 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555031714 | chr1:103914607-103914608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538461299 | chr1:103914632-103914633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs72692392 | chr1:103914661-103914662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556668901 | chr1:103914734-103914735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529594117 | chr1:103914776-103914777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142554350 | chr1:103914796-103914797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375756057 | chr1:103914797-103914798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547936832 | chr1:103914830-103914831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566161725 | chr1:103914878-103914879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs142727266 | chr1:103914989-103914990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375953132 | chr1:103914995-103914996 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs578201549 | chr1:103915035-103915036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12096158 | chr1:103915049-103915050 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs545342095 | chr1:103915052-103915053 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs189549317 | chr1:103915058-103915059 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs6657566 | chr1:103915062-103915063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181970407 | chr1:103915110-103915111 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368656557 | chr1:103915123-103915124 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527337031 | chr1:103915132-103915133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184747788 | chr1:103915140-103915141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555165181 | chr1:103915194-103915195 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188761620 | chr1:103915210-103915211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs547580400 | chr1:103915328-103915329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181553403 | chr1:103915385-103915386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533281607 | chr1:103915395-103915396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570251456 | chr1:103915400-103915401 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569349373 | chr1:103915445-103915446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146327802 | chr1:103915449-103915450 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs537446399 | chr1:103915454-103915455 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186034352 | chr1:103915455-103915456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191083252 | chr1:103915456-103915457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567022482 | chr1:103915457-103915458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs367622172 | chr1:103915479-103915480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553545613 | chr1:103915484-103915485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181467460 | chr1:103915499-103915500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hypoplastic left heart syndrome | 22349727 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 19812545 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Autism | 19287141 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:103913800-103914200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr1:103913800-103915400 | Enhancers | Adipose Nuclei | Adipose |
3 | chr1:103914000-103914600 | Enhancers | Fetal Heart | heart |
4 | chr1:103914000-103915400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr1:103914200-103914600 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr1:103914200-103914600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr1:103914200-103916200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr1:103914600-103914800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr1:103914600-103916200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr1:103914800-103915800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr1:103915600-103916200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr1:103915800-103916200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
13 | chr1:103920200-103920600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr1:104003600-104005400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
15 | chr1:104003800-104005400 | Enhancers | Muscle Satellite Cultured Cells | -- |
16 | chr1:104004600-104005200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
17 | chr1:104004600-104005200 | Enhancers | HUVEC | blood vessel |
18 | chr1:104004800-104005200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
19 | chr1:104004800-104005200 | Enhancers | HMEC | breast |
20 | chr1:104008600-104009600 | Weak transcription | Aorta | Aorta |
21 | chr1:104009600-104010400 | Strong transcription | Aorta | Aorta |
22 | chr1:104010400-104015800 | Weak transcription | Aorta | Aorta |